There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Moderna’s (NASDAQ:MRNA) Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus (RSV), ...

Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

The lawsuits specifically concern Moderna’s COVID-19 vaccine, Spikevax ... infringing upon the company’s mRNA patents back in April. At the time, Pfizer voiced confidence in its patent ...

Pfizer, BioNTech Win Bid to Invalidate CureVac's UK COVID Vaccine Patents LONDON (Reuters) -Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's ...

Pfizer-BioNTech: The Pfizer-BioNTech vaccine ... performing almost as well as the mRNA vaccines in their early trials. The FDA authorized an updated COVID vaccine from Novavax at the end of ...